The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Tuesday, October 10, 2017
The National Multiple Sclerosis Society has committed nearly $14 million to support 40 new MS research projects.
read more
The FDA awarded 15 new clinical trial research grants totaling more than $22 million to boost development of products for patients with rare diseases.
read more
Bristol-Myers Squibb has appointed Saurabh Saha, M.D., Ph.D. as senior vice president and global head of translational medicine in the company’s R&D ...
read more
Kadmon announced the FDA has granted orphan drug designation to KD025 for the treatment of chronic graft-versus-host disease.
read more
Cantargia AB announced that the United States Patent and Trademark Office has granted the company's patent application directed to the product ...
read more
Thursday, October 05, 2017
In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy effectively stabilized the disease's progression in 88 percent of ...
read more
Tuesday, October 03, 2017
Regen BioPharma scientists have used a standard biochemical assay to determine if some of its small molecules that have been shown to activate NR2F6 ...
read more
Wednesday, September 27, 2017
As an agency dedicated to promoting public health, and as fellow Americans, the staff at the FDA is doing all it can to support the immediate needs of...
read more
Wednesday, September 27, 2017
Thermo Fisher Scientific announced the launch of its new PureLink Fast Low-Endotoxin Plasmid Purification Midi and Maxi Kits.
read more
Wednesday, September 27, 2017
The FDA announced the names of the companies selected to participate in a first-of-its kind pilot program that will help revolutionize digital health ...
read more
Tuesday, September 26, 2017
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine candidate.
read more
Friday, September 22, 2017
Allergan announced top-line results from new data for the CENTAUR Phase 2b study which supports the anti-fibrotic efficacy and safety of Cenicriviroc ...
read more
Thursday, September 21, 2017
Provention has entered into agreements with Janssen Pharmaceutica NV and Janssen Sciences Ireland UC to in-license two clinical-stage assets, PRV-6527...
read more
Thursday, September 21, 2017
LabCentral and Pfizer announced plans to open LabCentral 610, a new LabCentral offering located at Pfizer’s Kendall Square Worldwide Research and ...
read more
Eppendorf expands its portfolio of rigid-wall single-use vessels for fermentation. The newly launched Eppendorf BioBLU® 3f was developed specifically ...
read more